روبرت جيه. ويلكنسون
Wilkinson, Robert
Wilkinson, Robert, verksam 1600-1610
VIAF ID: 1106802 (Personal)
Permalink: http://viaf.org/viaf/1106802
Preferred Forms
- 100 1 _ ‡a Wilkinson, Robert
- 100 1 _ ‡a Wilkinson, Robert
- 100 1 _ ‡a Wilkinson, Robert, ‡d verksam 1600-1610
- 100 0 _ ‡a روبرت جيه. ويلكنسون
4xx's: Alternate Name Forms (11)
Works
Title | Sources |
---|---|
Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis | |
Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis | |
Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome | |
Neutrophils: Innate Effectors of TB Resistance? | |
Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis | |
Pathogenesis of tropical pulmonary eosinophilia: parasitic alveolitis and parallels with asthma. | |
Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study | |
Peptide Recognition by T-Cell Clones of an HLA-DRB11501/0901 Heterozygous Donor is Promiscuous Only Between Parental Alleles | |
The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals | |
Pilgram-Straße der Heiligen Nach dem Lande Canaan. - | |
Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations | |
Population tailored modification of tuberculosis specific interferon-gamma release assay | |
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis | |
Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS | |
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis | |
Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London | |
The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting. | |
Primate model to study reactivation of TB associated with retroviral infection | |
Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis | |
Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis | |
Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting | |
QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response | |
QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? | |
Raised Venous Lactate and Markers of Intestinal Translocation Are Associated With Mortality Among In-Patients With HIV-Associated TB in Rural South Africa | |
Rapid diagnosis and determination of duration of viraemia in dengue fever using a reverse transcriptase polymerase chain reaction | |
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study | |
Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics | |
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis | |
Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients | |
Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas. | |
Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis | |
Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment | |
Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis | |
The road to drug resistance in Mycobacterium tuberculosis | |
Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages | |
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial | |
Safety implications of combined antiretroviral and anti-tuberculosis drugs | |
Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction | |
Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection | |
Selective T-cell recognition of the N-terminal peptide of GroES in tuberculosis | |
Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa | |
Southern Africa consortium for research excellence (SACORE): successes and challenges. | |
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies | |
Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies | |
Towards host-directed therapies for tuberculosis | |
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers | |
Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing | |
Tricks to translating TB transcriptomics. | |
Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority | |
Tuberculous meningitis: a uniform case definition for use in clinical research | |
Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity | |
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome | |
UK's role in global health research innovation. | |
Understanding and intervening in HIV-associated tuberculosis | |
Undiagnosed Active Tuberculosis in HIV‐Infected Patients Commencing Antiretroviral Therapy | |
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial | |
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa | |
Vitamin d and tuberculosis: new light on a potent biologic therapy? | |
Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D | |
Vitamin D in the treatment of pulmonary tuberculosis | |
Vitamin D Status and Its Consequences for Health in South Africa |